Centre of Reproductive Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Family Planning Research Institute/Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Vaccine. 2018 May 3;36(19):2612-2618. doi: 10.1016/j.vaccine.2018.03.071. Epub 2018 Apr 6.
uPA, a trypsin-like serine protease, was found to take active part in male reproduction. Our previous work had demonstrated the antifertility effects of its full length protein immunization, but with immune tolerance and other latent side effects. Here we discovered two effective B-cell epitopes of uPA for male contraception in growth factor-like domain and kringle domain respectively. Together with carrier protein, immunization of these two epitope peptides could induce high titers of specific antibodies in male mice. Significant reduction of fertility was observed in these two groups in mating trial without evident systemic illness or abnormal mating behavior. Epididymal sperms of immunized males exhibited impaired progressive motility and ability to fertilize eggs in vitro. The immunization of another predicted epitope in serine protease domain and the control groups showed no similar positive results. Importantly, T cells were not activated after the challenge of these B-cell epitopes itself, which suggests that these vaccines do not induce cell-mediated autoimmunity. Taken together, our study discovered two uPA B-cell epitopes as novel targets for male immunocontraception with minimum side effects. Considering their high identity with human uPA protein, these two epitope vaccines hold great promise to be developed for man use in the future.
uPA,一种胰蛋白酶样丝氨酸蛋白酶,被发现积极参与男性生殖。我们之前的工作已经证明了其全长蛋白免疫的抗生育效果,但存在免疫耐受和其他潜在的副作用。在这里,我们在生长因子样结构域和 Kringle 结构域中分别发现了 uPA 的两个有效的 B 细胞表位,用于男性避孕。与载体蛋白一起,这两种表位肽的免疫接种可以在雄性小鼠中诱导高滴度的特异性抗体。在没有明显全身疾病或异常交配行为的交配试验中,这两个组的生育能力显著降低。免疫雄性的附睾精子表现出受损的渐进运动和体外受精能力。在丝氨酸蛋白酶结构域中预测的另一个表位的免疫接种和对照组没有显示出类似的阳性结果。重要的是,这些 B 细胞表位本身的挑战并没有激活 T 细胞,这表明这些疫苗不会引起细胞介导的自身免疫。总之,我们的研究发现了 uPA 的两个 B 细胞表位,作为具有最小副作用的新型男性免疫避孕靶点。考虑到它们与人 uPA 蛋白的高度同源性,这些两种表位疫苗很有希望在未来开发用于人类使用。